LQDA vs MRK
Liquidia Corporation vs Merck & Co. — AI-powered side-by-side comparison
LQDA
Liquidia Corporation
68
Buy
VS
| Metric | LQDA | MRK |
|---|
| AI Score |
68
|
70
|
| Price |
$88.09
|
$130.34
|
| P/E Ratio |
368.26×
|
103.53×
|
| ROE |
-154.0%
|
34.7%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
91.8%
|
75.4%
|
| Debt / Equity |
1.70×
|
1.29×
|
| Dividend Yield |
0.0%
|
2.6%
|
| RSI (14) |
55.0
|
64.5
|
| Beta |
0.572
|
0.207
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for LQDA versus MRK.
MRK leads by 2 points.
MRK scores 70/100 (Buy) versus LQDA at 68/100 (Buy).
LQDA Committee View
67% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 46.8% shows genuine earnings power backing the valuation — Value
- Revenue growing 1936.7% YoY -- genuine top-line momentum — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- P/E of 362.9 is expensive by classic value standards — Value
- Price-to-book of 12.9x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical
MRK Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical